United States:
Health Law Diagnosed — Transactions Part 1: Regulatory Trends In Recent Health Care Transactions (Podcast)
To print this article, all you need is to be registered or login on Mondaq.com.
2021 was a busy year for Mintz's Health Law team, as they
helped clients navigate complex health care transactions. Listen to
hear the macro trends our team is seeing in the market, as well as
their takeaways from the deals they closed.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
